BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs7903146
,
MYC
,
T cell receptor signaling pathway
,
Influenza
,
Intestine
,
Fenofibrate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
myelokathexis
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
CXCR4
CXCR2
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
dendritic cell migration
MODULE_73
MODULE_265
MODULE_367
chemokine binding
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
OMIM - Unspecified immunity deficiency
OMIM - Congenital disorder
OMIM - Multisystem Complex Disorders
Explore Curated Studies Results
Literature
Most Relevant Literature
Clinical and Hematologic Effects of Endotoxin in Warts, Hypogammaglobulinemia, Infections, and Myelo…
Severe CD8+ T Lymphopenia in WHIM Syndrome Caused by Selective Sequestration in Primary Immune Organ…
Genotype-phenotype correlations in WHIM syndrome: a systematic characterization of CXCR4WHIM variant…
CXCR4 WHIM syndrome is a cancer predisposition condition for virus-induced malignancies.
Plerixafor on a WHIM - Promise or Fantasy of a New CXCR4 Inhibitor for This Rare, but Important Synd…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
AMD 3100 for Treatment of Myelokathexis
Efficacy and Safety Study of Mavorixafor in Participants With Warts, Hypogammaglobulinemia, Infectio…
A Dose Determination and Safety Study of X4P-001 (Mavorixafor) in Participants With Warts, Hypogamma…
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ